April 13, 2015
TVM Life Science Ventures VII today announced the fund’s seventh investment, a co-investment with the Fonds de solidarité FTQ (the “Fonds”) – establishing Esperas Pharma Inc., a company based in Montréal, Québec. Esperas Pharma Inc. plans to develop, to proof-of-concept, a compound originally discovered through one of Eli Lilly and Company’s (Lilly) research and development programs, with the potential to treat certain types of cancers including triple negative breast cancer.
April 8, 2015
A new chapter has opened in the history of Frima, Canada’s biggest independent videogame company, with the arrival of two new investors and partners, Fonds de solidarité FTQ and European entertainment powerhouse Média-Participations. The $7.5 million investment will equip the Quebec City studio to pursue its mission as a leader in the development and sale of entertainment products and brands.